Improving the health and well-being of patients affected by Alzheimer’s disease
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Ram Mukunda and Claudia Grimaldi from IGC Pharma, a clinical stage pharmaceutical company focused on improving the health and well-being of patients affected by Alzheimer’s disease and bringing these therapies...
mostra di più- Many people are aware of the symptoms of Alzheimer's including dementia, but many are unaware of that agitation is one of the most common and challenging aspects of care among patients with dementia due to Alzheimer’s disease. Can you explain why?
- How does this condition affect those caring for a patient affected by Alzheimer's?
- How does your investigational drug IGC-AD1 work to help these patients?
- What are the next steps in bringing this drug to market?
- What other therapies is IGC Pharma working on in Alzheimer’s?
Informazioni
Autore | eHealth Radio Network |
Organizzazione | eHealth Radio Network |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company